Area:
Alternative Medicine, Immunology, Molecular Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, Kamal D. Srivastava is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
2006 — 2008 |
Srivastava, Kamal D |
F31Activity Code Description: To provide predoctoral individuals with supervised research training in specified health and health-related areas leading toward the research degree (e.g., Ph.D.). |
Anti-Bronchoconstrictive Effect of the Tcm Formula Ashmi @ Mount Sinai School of Medicine of Nyu
[unreadable] DESCRIPTION (provided by applicant): This research proposal aims to characterize the anti-bronchoconstrictive effects of a Traditional Chinese Medicine anti-asthma formula ASHMI developed in our lab. Our hypothesis is that bioactive compounds present in ASHMI suppress bronchoconstriction by upregulating the production and activity of endogenous bronchodilators in the airways. Experiments designed to explore this hypothesis will be attempted using specific aims that will initially characterize the suppressive effects of ASHMI on airway contractility. We will investigate the efficacy, potency and reversibility of ASHMI anti-bronchoconstrictive effects. Subsequently we will investigate the cellular mechanisms mediating the suppressive effects of ASHMI on airway contractility. We will study potential regulation of bronchodilatory mediators such as PGE2 by ASHMI and also include studies on its possible effects on muscarinic signaling. Lastly, we will attempt to identify the bioactive agent(s) in ASHMI that are responsible for its suppressive action on airway contractility by adapting a simplified strategy that will first identify the key herb in the formula mediating its suppressive effects on contraction followed by further elaboration of the actual biocompound(s) by techniques such as HPLC, NMR and mass spectroscopy. [unreadable] [unreadable] [unreadable] [unreadable] [unreadable] [unreadable]
|
0.991 |